Explore more publications!

Press Releases

Novartis announces expansion of community health programs to close gaps in heart disease and cancer care, targeting more than 30 countries by 2030
Cybersecurity Market Surges to $351.92 billion by 2030 | CAGR 9.1%
Finnish MP Gets Convicted for Pamphlet Deemed Offensive to Gay People

Finnish MP Gets Convicted for Pamphlet Deemed Offensive to Gay People

Deafmetal Opens Seed Round and Launches Audiology Clinic Program to Scale Hearing Aid Jewelry Globally
Change in Orion Group Executive Team as of 8 April 2026 – Berkeley Vincent appointed Executive Vice President, Innovative Medicines
VIVUS Reinforces QSIVA®’s Clinical Efficacy and Safety in Obesity Management
Global Health Leaders to Convene in London for Inaugural International Case Management Conference
Herantis Pharma to present HER-096 Phase 1b data at International Conference on Alzheimer’s & Parkinson’s Diseases
Brisbane Surgeons Publish World-First Nomogram for Corneal Ring Segment Treatment of Keratoconus
Eyewear Market Report 2032: Industry Racing to USD 271.28 Billion at 8.19% CAGR, Reveals Maximize Market Research
Sauna bathing may boost immune responses
Power Generator Rental Market Size, Share & Forecast 2026–2032 | USD 4.06 Bn Growing at 5.1% CAGR
Amarin Highlights Guideline Recommended Role of Icosapent Ethyl in Managing Cardiovascular Risk Following Release of Updated 2026 ACC/AHA/Multisociety Dyslipidemia Guideline
Rover Reveals How Americans Are Redefining Pet Parenthood Across Generations
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
GLP-1 medications used to treat diabetes and obesity may also help alleviate symptoms of anxiety and depression
New REDUCE-IT Data in Patients at Extreme Cardiovascular Risk and In Vitro Research on the Mechanistic Effects of Eicosapentaenoic Acid (EPA) on Lipoprotein(a) [Lp(a)] Oxidation to be Presented at the American College of Cardiology’s (ACC) Annual…

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions